Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported fourth quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $3.25 on revenue of $6.51B. Analysts polled by Investing.com expected EPS of $3.18 on revenue of $6.23B. That compared to EPS of $2.79 on revenue of $6.05B in the same period a year earlier. The company had reported EPS of $2.62 on revenue of $5.92B in the previous quarter.
For the year, Thermo Fisher Scientific shares are up 5.86%, under-performing the S&P 500 which is up 6.98% year to date.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings matched analyst's expectations on Tuesday, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.64 on revenue of $13.96B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar